Acorda Therapeutics Licenses Rights To Investigational Treatment For Spinal Cord Injury And Traumatic Brain Injury
Acorda Therapeutics Licenses Rights To Investigational Treatment For Spinal Cord Injury And Traumatic Brain Injury
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has licensed worldwide development and commercialization rights to a proprietary magnesium formulation from Medtronic, Inc. (NYSE: MDT), which will be referred to as AC105…
